Rafael J. Grossmann, MD, FACS posted on LinkedIn
From a newspaper during the 1918 pandemic. Do we ever learn?…
From a newspaper during the 1918 pandemic. Do we ever learn?…
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase…
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase…
Drug discovery is an incredibly daunting task. The needle in a haystack analogy might be a bit overused, but it’s an apt way to describe…
From protocol development to timely recruitment and retention to regulatory approval, it is crucial that trial subjects feel involved, retain their autonomy…
A few days ago, I was reading “Brandsplaining”, a book that made my brain churn tons of thoughts. And I cannot help but share those…
👀 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗼𝗳 𝗟𝗟𝗠𝘀 𝗮𝗻𝗱 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗽𝗿𝗼𝘃𝗶𝗱𝗲𝗿𝘀? It’s been a whirlwind since… | 10 comments on LinkedIn
Eric Herzog, CMO at Infinidat “As we recognize World Backup Day 2024, the industry needs to acknowledge backup has dramatically changed so much that new…
Join us for a symposium on ulcerative colitis (UC) designed to encourage the exchange of ideas between leaders in the field and attendees. This event…
Stress and burnout may be the result of poorly executed onboarding, insufficient resources and support, and workplace environment and culture.
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase…